Search our website

Press Releases

Menu
2023
May 15, 2023
VBI Vaccines Reports First Quarter 2023 Financial Results
Categories: Press Releases
April 25, 2023
VBI Vaccines Appoints Vaughn Himes to Board of Directors
Categories: Press Releases
April 4, 2023
VBI Vaccines Announces Increased Focus on Hepatitis B, Organizational Changes, and Reverse Stock Split
Categories: Press Releases
March 13, 2023
VBI Vaccines Reports Full Year 2022 Financial Results
Categories: Press Releases
February 23, 2023
VBI Vaccines to Discuss Progress in Hepatitis B Portfolio in Analyst-Led Fireside Chat
Categories: Press Releases
February 15, 2023
VBI Vaccines Announces Presentation of Interim Phase 2 Data Evaluating Combination of VBI-2601 (BRII-179) and BRII-835 for the Treatment of Chronic Hepatitis B
Categories: Hepatitis B, Posters, Press Releases
Browse by Year
Media icon chat

Media Contact

Nicole Anderson

Director, Corporate Communications & Investor Relations

Telephone: (617) 830-3031 x124

Email: IR@vbivaccines.com

Media icon paper

Media Kit

Download multimedia resources including web and print logos.

DownloadArrow

Sign-up for Our Distribution List to Receive the Latest News and Updates from VBI

Sign Up Now for our newsletterArrow
Go top